Changes to Hepatitis C Treatment
February 1, 2019
Hepatitis C Treatment - Update to pathway and claiming process
The Chronic Hepatitis C pathway has been updated for the newly funded direct acting antiviral (DAA) medication, Maviret™.
Maviret™ is the recommended treatment in primary care for a majority of patients with Hepatitis C who do not have cirrhosis:
Cure rate of 99%...
New Abscess Management Pathways
January 31, 2019
Primary Care communications for new abscess management pathways
Auckland Regional HealthPathways has developed three new pathways for abscess management:
Skin and soft tissue abscess in adultsBartholin's cyst or abscess Mastitis and breast abscess
These best practice regionally agreed pathways have been developed with both primary a...
Hospital Referral to Urgent Care/GP Clinic
January 15, 2019
The process for hospital referrals under POAC:
When a patient attends Urgent Care with a hospital discharge summary stating for further POAC funded treatment, this includes the following principles:
The Urgent Care clinic generates the POAC referral/case number when the patient attendsThe initial consult and all treatmen...
Christmas and New Year Holiday Period
December 20, 2018
POAC OVER THE HOLIDAY PERIOD
Thank you for your support over the year, we look forward to an exciting 2019.
From our team to yours, Merry Christmas and a safe and happy holiday season!
POAC HOURS OVER THE HOLIDAY:
The POAC coordinators are taking a well deserved break over the Christmas and ...
Pelvic Ultrasound Funding
November 7, 2018
POAC funds pelvic ultrasound scans for the following conditions:
Suspected retained products of conception beyond Section 88 funded scan time period.
Persistent, heavy PV bleeding lasting more than 2 weeks following miscarriage or termination of pregnancy, or more than 6 weeks post-delivery, to rule out retained products of conception. Fo...
Rivaroxaban funding
September 17, 2018
Rivaroxaban not indicated or funded before POAC DVT scan
In line with the Auckland Regional HealthPathway, when there is a delay in obtaining community ultrasound for DVT, Enoxaparin continues to be the medication to be administered and funded through POAC.
The issue of using rivaroxaban instead of enoxaparin for anticoagulation c...
DVT Risk Stratification
June 27, 2018
A reminder that the first action for suspected DVT is completion of Wells Score.
ONLY if <2 is a d-dimer required. If score is 2 or more then proceed directly to request for ultrasound.
Awaiting d-dimer delays the ultrasound request and this may not be necessary
For...
Antibiotics in sore throat and tonsilitis
June 8, 2018
Antibiotics in Acute Sore Throat or Tonsilitis
Background
In patients at low risk of rheumatic fever, antibiotics should only be prescribed if the patient is severely unwell. ≥ 70% of sore throats will be viral and do not need antibiotic treatment.
For risk stratification and management of sore throat see sore thr...
ECG funding under POAC
April 16, 2018
The following principles apply when considering ECG funding under POAC
CHEST PAIN
Patients who present with current pain and high suspicion of ACS - admit as per regional acute chest pain pathway. Any management awaiting ambulance transfer is standard care and POAC...
NEW POAC Nurse Advisor
February 9, 2018
Welcome back to Sarah Hyder
We welcome back to the POAC team Sarah Hyder in the role of POAC Regional Nurse Advisor.
Sarah qualified as a registered nurse in 1993 and has held senior nursing positions in Auckland since 2004. These include Clinical Nurse Specialist in Haematology, where Sarah presented ...
Loading...
TAGS
abscessdvtECGAcute ECGantibioticBARTHOLIN'S ABSCESSboilBREAST ABSCESScellulitiscephazolincystectopicFAQsFerinjectgynaeHep CHepatitisIVIV ironmaternityMaviretNurse AdvisorOSTovarianovarian cystovarian torsionpaediatric cellulitispelvic scanpelvic ussPIDPOAC ECGpoac pelvic\RivaroxabanSarah Hydersore throattonsilitisTroponinwells score
Loading...